Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Natus Medical, Inc. (NASDAQ: BABY).

Full DD Report for BABY

You must become a subscriber to view this report.


Recent News from (NASDAQ: BABY)

Research Report Identifies Citrix, Ameriprise Financial, Natus Medical, Alphabet, Amazon, and MarketAxess with Renewed Outlook - Fundamental Analysis, Calculating Forward Movement
NEW YORK, Oct. 30, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Citrix Systems, Inc. (NASDAQ:CTXS), Ameriprise Financial, Inc. (NYSE:A...
Source: GlobeNewswire
Date: October, 30 2018 08:35
Trump to terminate birthright citizenship
President Trump plans to sign an executive order that would remove the right to citizenship for babies of non-citizens and unauthorized immigrants born on U.S. soil, he told Axios on HBO . More news on: Kimberly-Clark Corporation, The Procter & Gamble Company, Johnson & Johnson,...
Source: SeekingAlpha
Date: October, 30 2018 06:30
Detailed Research: Economic Perspectives on The Michaels Companies, Glu Mobile, Natus Medical, Progenics Pharmaceuticals, QuinStreet, and Jaguar Health - What Drives Growth in Today's Competitive Landscape
NEW YORK, Aug. 27, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of The Michaels Companies, Inc. (NASDAQ:MIK), Glu Mobile Inc. (NASDAQ:GLUU),...
Source: GlobeNewswire
Date: August, 27 2018 07:55
Natus Medical Inc. (BABY) CEO Jonathan Kennedy on Q2 2018 Results - Earnings Call Transcript
Natus Medical Inc. (BABY) Q2 2018 Results Earnings Conference Call July 25, 2018, 11:00 AM ET Executives Jonathan Kennedy - President and CEO Sharon Villaverde - Interim CFO Analysts Andrew Brackmann - William Blair Jayson Bedford - Raymond James David Solomon - ROTH Capi...
Source: SeekingAlpha
Date: July, 25 2018 14:44
Natus Medical Q2 top line up 7%; non-GAAP EPS up 3%; lowers fiscal guidance
Natus Medical ( BABY +14.5% ) Q2 results : Revenues: $130.7M (+7.0%); Operating Loss: ($3.8M) (+39.7%); Net Loss: ($2.6M) (+48.0%); Loss Per Share: ($0.08) (+46.7%); Non-GAAP EPS: $0.35 (+2.9%); Non-GAAP Net Income: $11.6M (+3.6%); Quick Assets: $54.9M (-14.9%); CF Ops: $5M (-44.4%). Mo...
Source: SeekingAlpha
Date: July, 25 2018 09:55
Natus Medical Incorporated to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / July 25, 2018 / Natus Medical Incorporated (NASDAQ: BABY ) will be discussing their earnings results in their Q2 Earnings Call to be held on July 25, 2018 at 11:00:00 AM Eastern Time. To listen to the event live or access a replay of the call - visit https://w...
Source: ACCESSWIRE IA
Date: July, 25 2018 09:00
Natus Medical beats by $0.09, beats on revenue
Natus Medical (NASDAQ: BABY ): Q2 EPS of $0.35 beats by $0.09 . Revenue of $130.65M (+6.9% Y/Y) beats by $0.15M . Press Release More news on: Natus Medical Incorporated, Earnings news and commentary, Healthcare stocks news,
Source: SeekingAlpha
Date: July, 25 2018 06:03
Natus Medical Announces Second Quarter Financial Results
Reports record second quarter revenue of $130.7 million Reports second quarter GAAP loss per share of $0.08 and non-GAAP earnings per share of $0.35 Updates annual revenue and earnings guidance for 2018 PLEASANTON, Calif., July 25, 2018 (GLOBE NEWSWIRE) --  Natus Medical...
Source: GlobeNewswire
Date: July, 25 2018 06:00
Natus Medical promotes Kennedy to CEO as Hawkins retires
Natus Medical (NASDAQ: BABY ) names Jonathan Kennedy its new President and CEO , effective immediately, succeeding Jim Hawkins, who is retiring after 14 years as CEO. More news on: Natus Medical Incorporated, Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: July, 11 2018 19:10
Natus Medical Announces Leadership Changes
Jim Hawkins Retires after 14 years as President and CEO Jonathan Kennedy Appointed President and Chief Executive Officer Board Appoints Barbara Paul, M.D. Chairperson Releases Preliminary Q2 2018 Revenue and Conference Call Date PLEASANTON, Calif., July 11, 2018 (GLOBE NEWSW...
Source: GlobeNewswire
Date: July, 11 2018 17:00

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-0733.9233.5433.9233.29240,079
2018-12-0633.6833.9634.3133.36235,401
2018-12-0435.0934.1135.1033.68292,349
2018-12-0335.6835.2535.7335.01324,715
2018-11-3035.0235.3835.5534.86542,218

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-0739,56168,60857.6624Short
2018-12-0630,30841,07573.7870Short
2018-12-0448,11761,93177.6945Short
2018-12-0340,27763,12663.8041Short
2018-11-3023,48652,71944.5494Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on BABY.


About Natus Medical, Inc. (NASDAQ: BABY)

Logo for Natus Medical, Inc. (NASDAQ: BABY)

Not available

 

Contact Information

 

 

Current Management

  • Tim C. Johnson / CEO, President, COO, Secretary
  • William H. Lawrenson / CFO

Current Share Structure

  • Market Cap: $1,170,563,108 - 05/14/2018
  • Issue and Outstanding: 33,160,428 - 02/21/2018

 


Recent Filings from (NASDAQ: BABY)

Proxy soliciting materials. Revised preliminary material
Filing Type: PRER14AFiling Source: edgar
Filing Date: May, 17 2018
Non-management revised preliminary proxy soliciting materials
Filing Type: PRRN14AFiling Source: edgar
Filing Date: May, 15 2018
Proxy soliciting materials. Revised preliminary material
Filing Type: PRER14AFiling Source: edgar
Filing Date: May, 11 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 09 2018
Preliminary proxy statement containing contested solicitations
Filing Type: PREC14AFiling Source: edgar
Filing Date: May, 07 2018
Proxy soliciting materials. Revised preliminary material
Filing Type: PRER14AFiling Source: edgar
Filing Date: May, 04 2018
Preliminary proxy statement containing contested solicitations
Filing Type: PREC14AFiling Source: edgar
Filing Date: May, 02 2018
Amendment to a previously filed 10-K
Filing Type: 10-K/AFiling Source: edgar
Filing Date: April, 30 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 25 2018
Additional proxy soliciting materials filed by non-management
Filing Type: DFAN14AFiling Source: edgar
Filing Date: April, 23 2018

 

 


Daily Technical Chart for (NASDAQ: BABY)

Daily Technical Chart for (NASDAQ: BABY)


Stay tuned for daily updates and more on (NASDAQ: BABY)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: BABY)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in BABY is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of BABY and does not buy, sell, or trade any shares of BABY. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/